Home › Drug Codes › J Codes › J3394 · Lyfgenia
Updated October 1st, 2026

Lyfgenia J Code: J3394

Injection, lovotibeglogene autotemcel, per treatment

Login to unlock all benchmarks
Medicare Payment Limit ?
Not published
CMS publishes none for Q4 2026
APC Payment Limit ?
$3,235,299.489
/ HCPCS billing unit · APC 0748
ASP ?
No current ASP
Not available for Q4 2026
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
1
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, lovotibeglogene autotemcel, per treatment
HCPCS Added Date July 1, 2024
Manufacturer Genetix Biotherapeutics
Route of Administration Intravenous
Generic Status Single-Source; Branded
Dosage Form Suspension

About Lyfgenia

Lyfgenia is a medication aligned to the HCPCS J Code: J3394 for billing, pricing, and reimbursement purposes in the United States. It is a Genetic Disorder drug administered via the intravenous route and manufactured by Genetix Biotherapeutics.

Manufacturers, reach out to us to add more information.

NDC Code Information

1 NDC package is crosswalked to J3394. Package detail is available to logged-in subscribers.

Login to view 1 NDC package View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

Lyfgenia Pricing & Reimbursement

J3394 Private Payer Reimbursement
$7,762.50 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Lyfgenia CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96413 Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415 Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)
Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

Lyfgenia Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Sickle cell disease

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Lyfgenia billing and coding guide?
Billing and coding information for Lyfgenia can be found through Bluebird Bio, Inc.. Visit Here →
Are there any available Lyfgenia patient assistance programs?
Lyfgenia patient assistance information can be found through Bluebird Bio, Inc.. Visit Here →
Where can I find Lyfgenia prescribing information?
Lyfgenia prescribing information can be found at the link below: Visit Here →
Where can I find Lyfgenia side effect information?
Information regarding Lyfgenia's side effect information can be found at Medline Plus.
Does billing Lyfgenia require JZ/JW wastage modifiers?
CMS does not include Lyfgenia (J3394) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J3394. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.